Human Challenge Studies in Vaccine Development: Expert Insights on AMR | ISAC Webinar

This ISAC webinar by the Rapid Diagnostics and Biomarkers Working Group explores how controlled human infection models (CHIMs) accelerate vaccine development for pertussis, Salmonella, and malaria. Leading researchers discuss study design, ethics, regulatory considerations, and the implications for antimicrobial resistance (AMR). Ideal for scientists, clinicians, public health professionals, and vaccine developers. 00:00 Start 00:12 Introduction - Prof. Kordo Saeed 01:54 Leveraging human challenge models for pertussis vaccine development - Dr Adam Dale 27:30 Human Challenge Models for Salmonella to Accelerate Vaccine Development - Dr Malick Gibani 58:51 The Malaria Challenge: the valuable role of controlled human malaria infection models (CHMIs) in malaria vaccine development - Dr Jennifer van Heerden human challenge studies, controlled human infection models, CHIM, CHMI, vaccine development, pertussis vaccine, Salmonella vaccine, malaria vaccine, AMR, antimicrobial resistance, ISAC webinar, APUA, vaccine research, infectious disease, clinical trials